Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 84 results for "dusa pharmaceuticals"

The DNA of Ranbaxy Laboratories Ltd lives on... We have a perfect fit, says Sun Pharma chairman
Financial Express

The DNA of Ranbaxy Laboratories Ltd lives on... We have a perf...

Israel Makov's tenure as chairman of Sun Pharmaceuticals Industries has seen three acquisitions — URL Pharma, Dusa Pharmaceutical and now Ranbaxy Laboratories — and a joint venture to develop therapies for ocular diseases with US-based Intrexon. Financial Express, 1 week ago

Caliber Imaging & Diagnostics Names Richard C. Christopher to Chief Financial Officer

GlobeNewswire 2014-03-20 Former CFO of DUSA Pharmaceuticals Provides Financial and Industry Strength to Executive Management Team BOSTON and ROCHESTER, N.Y., March 20, 2014 (GLOBE NEWSWIRE) -- Caliber Imaging & Diagnostics (OTCQB:LCDX), ...
 BizWire Express4 weeks ago Caliber Imaging & Diagnostics elects Richard C. Christopher as CFO  Individual.com3 weeks ago

Accumulate Sun Pharma; target of Rs 646: P Lilladher

Prabhudas Lilladher's report on Sun Pharmaceutical Industries "Sun Pharma acquired Ranbaxy at an all-stock deal of USD 4bn, including equity value of USD 3.2bn and debt of USD 800m. Per deal, Ranbaxy to merge with Sun Pharma at a stock swap ratio ...
 Moneycontrol.com6 days ago Ranbaxy deal to push Sun Pharmaceutical's global growth  BDlive1 week ago Sun Pharma buys Ranbaxy for $3.2b, turns it Indian again  The Financial Chronicle1 week ago Dilip Shanghvi,Sun Pharma promoter, a pharma maven with midas touch  Economic Times1 week ago

Ranbaxy buy in line with Sun's strategy

Sun Pharma’s recent purchase of ailing Ranbaxy Laboratories might have come as a surprise but analysts said the deal was in sync with the character of Mumbai-headquartered drug maker, known for its turnaround talent. In fact, most buyouts by Sun, on an acquisition spree since the late 90s, have worked well. The company buys distressed assets across the globe and turns them around to not only add to its books but also its product pipeline and regions. Since 1996, the company has done 16 ...
 Rediff.com1 day ago Sun Pharma and Ranbaxy together will be stronger  Manufacturing Chemist1 week ago Sun Pharma-Ranbaxy deal: Sunshine for Ranbaxy  Smart Investor1 week ago Sunshine for Ranbaxy  Business Standard India1 week ago

Can Sun Pharma defy law of averages on MA deal trend?

Majority of corporate mergers/acquisitions end up destroying shareholder wealth more often than not. Shareholders of Sun Pharma, however, have not had reason to complain, even the company has been on an acquisition spree since the late 90s. Most of ...
 Moneycontrol.com1 week ago

Sun Pharma to face challenges in rectifying quality control

Sun Pharma management may face considerable challenges in rectifying a long history of quality control and regulatory problems plaguing Ranbaxy's recent performance, according to analysts. But given Sun Pharma's managing director Dilip Shanghvi's ...
 Financial Chronicle1 week ago

Sun Pharma buys Ranbaxy to create generics giant

The merged company after Sun Pharma's Ranbaxy acquisition will become the world's fifth-largest specialty generics company and the largest drug firm in India. Photo: Hemant Mishra/Mint Sun Pharma will acquire 100% stake of Ranbaxy in an all-stock ...
 Livemint.com1 week ago Sun Pharma shares fall as much as 6% after FDA import alert on Gujarat plant [Mint, New Delhi :: ]  BusinessWeek1 month ago

India's Sun to Acquire Ranbaxy in $3.2 Billion Stock Deal

(Updates with analyst's comment in fifth paragraph.) April 7 (Bloomberg) -- Sun Pharmaceutical Industries Ltd., India's largest drugmaker by market value, agreed to buy competitor Ranbaxy Laboratories Ltd. for $3.2 billion in stock to bolster sales ...
 Washington Post1 week ago
Business Standard India

Sun Pharma: All the right ingredients

Related to : Sun Pharmaceuticals Industries Ltd Sun Pharmaceuticals Industries Ltd BSE 14 Mar 14 | 12:00 AM 581.75 8.15 (1.42%) NSE 14 Mar 14 | 12:00 AM 582.05 9.1 (1.59%) Outperforms Sensex Market returns: 28.7% Sun Pharma ...
 Smart Investor1 month ago

Tekmira Pharmaceuticals Corporation And Theralase Technologies Inc. Leaders in Innovative Drug Therapies

) - Highlighted Links Viral Network Inc. The following is being issued by Viral Network Inc.: Without aggressive research and regulatory approval, cancer could soon overtake heart disease as the leading cause of ...
 BioSpace2 weeks ago Tekmira and Theralase Leaders in Innovative Drug Therapies  Individual.com2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less